What is the LumiraDx Limited stock price forecast?

LumiraDx Limited is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.

What is LumiraDx Limited insider trading activity?

View the latest insider trading data for LumiraDx Limited on Alpha Lenz.

What is LumiraDx Limited's P/E ratio?

LumiraDx Limited's P/E ratio is -0.0.

LumiraDx Limited

NASDAQ · LMDX

$0.02+0.00(+0.00%)Pre-market

Ask about LumiraDx Limited's future dividend policy...

Alpha Chat Insight

“LumiraDx Limited trades at a P/E of -0.0 (undervalued) with modest ROE of -1545.6%.”

Ask for details →

Company Overview

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.

CEOMs. Veronique Ameye EMBA, Esq., M.B.A.

Websitehttps://www.lumiradx.com

SectorHealthcare

IndustryDiagnostics & Research

Employees1,210

Company Statistics

FY 2022

Profile

$4.52MMarket Cap

$254.48MRevenue

0.00Shares Out

1,210Employees

Margins

-13.87%Gross

-109.58%EBITDA

-126.78%Operating

-174.20%Pre-Tax

-175.89%Net

Valuation

-0.01P/E

-0.04P/B

0.02EV/Sales

-1.08EV/EBITDA

-0.02P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-82.45%ROA

-1545.63%ROE

-73.65%ROIC

Financial Health

$100.01MCash & Cash Equivalents

$446.38MNet Debt

-518.52%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“LumiraDx Limited trades at a P/E of -0.0 (undervalued) with modest ROE of -1545.6%.”

Ask for details →

Frequently Asked Questions

LumiraDx Limited (ticker: LMDX) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,210 employees. Market cap is $5M.

The current price is $0.016 with a P/E ratio of -0.01x and P/B of -0.04x.

ROE is -1545.63% and operating margin is -126.78%. Annual revenue is $254M.